Transplanting purified allogeneic blood-forming stem cells in mice with a condition that closely resembles human systemic lupus erythematosus can stabilize or even reverse the disease, according to a study by Cellerant Therapeutics. Researchers also noted that even with mismatched donors and recipients, grafting was successful and graft-versus-host disease was not a problem.

Related Summaries